CONTRAST-ENHANCED ULTRASOUND STADY OF KIDNEYS IN PATIENTS WITH TYPE 2 DIABETES WITH THE POSSIBILITY OF A NEW DOSAGE OF THE CONTRAST-ENHANCED AGENT

Authors

  • O. Gorbatenko Fundamental research laboratory “Diagnostic researches and minimally invasive technologies”, Smolensk State Medical University, the Ministry of Health of the Russian
  • A. Borsukov Fundamental research laboratory “Diagnostic researches and minimally invasive technologies”, Smolensk State Medical University, the Ministry of Health of the Russian Federation

Keywords:

contrast-enhanced ultrasound, angionephrosclerosis, type 2 diabetes

Abstract

Aim of the research.Тo evaluate the diagnostic efficacy of the contrast-enhanced ultrasound examination of kidneys in patients with type 2 diabetes with a dose of injected contrast agent – 1.0 ml.

Materials and methods. 15 patients with verified type 2 diabetes. The age of the examined patients was 3561 years. The average age is 48 ± 1.7 years. All patients underwent complex diagnostics, including: ultrasound examination of kidneys in B-mode with vascular diagnostics in Color Doppler mode. Also, all patients underwent contrast-enhanced ultrasound (CEUS) examination of kidneys. Then, CEUS of kidneys was carried out using an contrast-enhanced agent "SonoVue" at a dose of 2.5 ml (in accordance with the European guidelines for clinical practice on contrast-enhanced ultrasound examination) and at a dose of 1.0 ml.

Results. As a result of improved technique (1.0 ml of an contrast-enhanced agent intravenously) in patients with type 2 diabetes, the qualitative and quantitative indicators were identical, or slightly reduced and did not affect the interpretation of the result.

Conclusion. The improved CEUS technique with 1.0 ml of contrast agent showed the possibilities in diagnosing diabetic nephropathy in patients with type 2 diabetes.

Downloads

Published

2021-03-22

Issue

Vol. 5 No. 11(63) (2020)

Section

Статьи

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

CC BY-ND

A work licensed in this way allows the following:

1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.

2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."

2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.